SCHEMBL9526067

SCHEMBL9526067

COc1ccc(S(=O)(=O)NC(=O)Nc2ccc(Br)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.76
EGFR P00533 1/20 0.62
ERBB2 P04626 1/20 0.62
IDO1 P14902 2/20 0.62
HSD17B10 Q99714 1/20 0.59
CA12 O43570 2/20 0.57
CA1 P00915 2/20 0.57
CA2 P00918 2/20 0.57
CA9 Q16790 2/20 0.57
HRH3 Q9Y5N1 1/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
KCNA1 Q09470 1/20 0.56
KCNAB1 Q14722 1/20 0.56
FPR2 P25090 1/20 0.55
MEN1 O00255 1/20 0.54
CYP2C9 P11712 1/20 0.54
KMT2A Q03164 1/20 0.54
MAOA P21397 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6467685 0.89 HSD17B10 (0.61) POLBIDO1HSD17B10CA12CA1
SCHEMBL9487965 0.88 CA1 (0.65) POLBEGFRERBB2IDO1CA12
SCHEMBL5187356 0.87 CA12 (0.70) POLBEGFRHSD17B10CA12CA1
SCHEMBL9526174 0.86 PPIA (0.64) POLBEGFRERBB2HSD17B10CA12
SCHEMBL7777663 0.86 LMNA (0.71) POLBEGFRERBB2HSD17B10CA12
SCHEMBL8621686 0.86 LMNA (0.62) POLBEGFRERBB2HSD17B10CA12
SCHEMBL8662949 0.85 HRH3 (0.72) POLBHSD17B10CA12CA1CA2
SCHEMBL6467353 0.85 SAE1 (0.71) POLBEGFRERBB2HSD17B10CA12
SCHEMBL9489786 0.84 KMT2A (0.74) EGFRERBB2CA12CA1CA2
SCHEMBL6463039 0.84 HSD17B10 (0.60) POLBIDO1HSD17B10CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0166615-B1 IMPROVEMENTS IN OR RELATING TO BENZENESULFONAMIDO DERIVATIVES ELI LILLY AND COMPANY (US) 1993-05-26 EP disclosed
US-5110830-A Benzenesulfonamides treatment of tumors susceptible to ELI LILLY AND COMPANY (US) 1992-05-05 US disclosed
US-4845128-A ANTITUMOR ELI LILLY AND COMPANY (US) 1989-07-04 US disclosed
EP-0166615-A2 Improvements in or relating to benzenesulfonamido derivatives ELI LILLY AND COMPANY (US) 1986-01-02 EP disclosed